Pharmaceuticals Government Tenders in Poland

Registration, quality assurance and the shape of a medicines contract

A medicines tender is decided on quality assurance before it is decided on price. Bidders must show that the product is authorised or registered for use in the destination market, that it is manufactured at a site holding current good manufacturing practice certification, and -- for many donor-funded and essential medicines programmes -- that the product or its manufacturer appears on a recognised prequalification list. These are documentary conditions of admissibility assessed against the specific product and manufacturing site offered, and a change of site after award is a contractual event, not an administrative one.

Products are specified by international non-proprietary name, strength and dosage form so that generics compete openly, with pharmacopoeial standards cited for quality. Delivery conditions carry as much weight as the product: a minimum proportion of shelf life remaining on arrival, batch certificates of analysis, tamper-evident and correctly labelled packaging in the required language, and unbroken cold chain with temperature monitoring for products that need it. A consignment that arrives with too little shelf life left is routinely rejected at the buyer's cost to the supplier.

The commercial structure is usually a framework at agreed unit prices with call-offs against forecast rather than firm volume, because demand depends on disease patterns and programme funding. That places emphasis on lead times, on the supplier's obligation to hold or replenish stock, and on what happens in a shortage -- allocation, substitution and notification terms are increasingly explicit. Recall capability is tested rather than assumed: buyers ask how quickly a batch can be traced and withdrawn from every facility it reached.

This section describes how this category is bought generally, across the public buyers that publish it. The figures elsewhere on this page are measured for this market alone.

Who buys pharmaceuticals in Poland?

GlobalGov holds 2,781 pharmaceuticals records from 637 distinct buying organisations in Poland. The most frequent publishers are Instytut Zootechniki - Państwowy Instytut Badawczy 31-047 Kraków, ul. Sarego 2 Zakład Doświadczalny Pawłowice (104 records); Krajowa Izba Odwoławcza (44 records); International buyer (34 records); PGE Energia Ciepła S.A. (29 records); Miejskie Przedsiębiorstwo Wodociągów i Kanalizacji w m. st. Warszawie S.A. (26 records); PGE Górnictwo i Energetyka Konwencjonalna S.A. (25 records). Between them the 6 largest account for 9.4% of everything published, so buying here is spread across many separate authorities.

What are pharmaceuticals contracts worth in Poland?

588 of the 2,781 records publish a contract value. The median is $200,156 and the largest single published value is $3.6B. By size, 149 under $100k, 268 between $100k and $1M, 150 between $1M and $10M, 21 above $10M. The remaining 2,193 publish no value at all, so every figure here describes the priced subset only, and values are as stated by the buyer rather than as finally awarded.

How long do bidders get to respond to pharmaceuticals tenders in Poland?

Across the 1,300 Poland pharmaceuticals notices that publish both a publication date and a closing date, the median response window is 34 days. A quarter of them allowed 32 days or fewer and a quarter stayed open for more than 36. Short turnarounds are the exception rather than the rule here: only 35 (2.7%) closed within a fortnight of being published.

How often are pharmaceuticals tenders published in Poland?

Poland publishes about 75 notices a month in this category, 896 in the last twelve months. That is 135% more than the 382 published in the twelve months before that. Over the last three years there were 1,536, spread across 84 separate months of activity since 11 June 2016. February is historically the busiest month. The most recent was published 18 September 2026.

How does Poland compare with other pharmaceuticals markets?

Among the 39 countries where GlobalGov holds a comparable pharmaceuticals market, Poland ranks 4th by number of records. The largest is Germany (4,115 records against 2,781 here). Within Poland itself, pharmaceuticals is the 12th largest of the 73 procurement categories tracked here.

Where do the Poland pharmaceuticals records on this page come from?

These 2,781 records are collected from 2 official sources: TED (2,569), e-Zamowienia (212). GlobalGov is an independent aggregator and is not affiliated with any of them; each record links back to the notice on its issuing portal. The set is rebuilt nightly, and the counts on this page were taken on 2026-10-01.

Most recent Pharmaceuticals tenders in Poland

None of these are open for bids now — they are the most recent records GlobalGov holds for this market, kept here so the shape of a typical pharmaceuticals notice in Poland is visible. Set an alert to be told when the next one opens.

Other procurement categories in Poland

Pharmaceuticals procurement in other markets